Stephanie L Safgren

Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study

Marvin D Nelson, P. Adamson, J. Perentesis, 2010, Pediatric blood & cancer.

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Fergus J Couch, Zeruesenay Desta, David A Flockhart, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.